N@N

Graig Suvannavejh Reiterated (AXSM) at Strong Buy and Held Target at $84 on, Mar 13th, 2023

Graig Suvannavejh of Mizuho, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $84 on, Mar 13th, 2023.

Graig has made no other calls on AXSM in the last 4 months.

There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 2 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $85 on, Tuesday, February 28th, 2023
• David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023

These are the ratings of the 5 analyists that currently disagree with Graig

---

• Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $210 on, Monday, March 6th, 2023
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, February 28th, 2023
• Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
• Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
• Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022

Contributing Sources

---